Loading insider details...
Latest Form 4 (Aug 4, 2026): Grant/Award of 7,500 JSPR shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Aug 4, 2026 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| Jul 28, 2026 | Scribe Therapeutics, Inc. (SCTX) | Purchase | 3,000 | $45.0K |
| May 13, 2026 | aTYR PHARMA INC (ATYR) | Grant/Award | 50,000 | n/a |
| Sep 24, 2025 | Jasper Therapeutics, Inc. (JSPR) | Purchase | 20,000 | $48.6K |
| Jul 3, 2025 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 7,500 | n/a |
| May 2, 2025 | aTYR PHARMA INC (ATYR) | Grant/Award | 50,000 | n/a |
| Jun 20, 2024 | Jasper Therapeutics, Inc. (JSPR) | Grant/Award | 15,000 | n/a |
| May 23, 2024 | aTYR PHARMA INC (LIFE) | Grant/Award | 24,000 | n/a |
| May 19, 2023 | aTYR PHARMA INC (LIFE) | Grant/Award | 12,000 | n/a |
| Apr 28, 2023 | aTYR PHARMA INC (LIFE) | Exercise/Conversion | 6,000 | n/a |